A systematic review of emerging technologies to enhance the treatment of ovarian cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A systematic review of emerging technologies to enhance the treatment of ovarian cancer
Authors
Keywords
-
Journal
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
Volume 28, Issue 7, Pages 660-677
Publisher
Informa UK Limited
Online
2023-07-07
DOI
10.1080/10837450.2023.2233588
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent advances in anti-multidrug resistance for nano-drug delivery system
- (2022) Changduo Wang et al. DRUG DELIVERY
- Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery
- (2022) Sankha Bhattacharya et al. DRUG DELIVERY
- The Therapeutic Effects of DDP/CD44-shRNA Nanoliposomes in AMF on Ovarian Cancer
- (2022) Ting Guo et al. Frontiers in Oncology
- Polyglycerol-based hydrogels and nanogels: from synthesis to applications
- (2021) Meena Kumari et al. Future Medicinal Chemistry
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- hTERT-molecular targeted therapy of ovarian cancer cells via folate-functionalized PLGA nanoparticles co-loaded with MNPs/siRNA/wortmannin
- (2021) Somayyeh Ghareghomi et al. LIFE SCIENCES
- Controlled Drug Delivery Systems: Current Status and Future Directions
- (2021) Shivakalyani Adepu et al. MOLECULES
- A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian cancer
- (2020) Bradley J. Monk et al. GYNECOLOGIC ONCOLOGY
- Development of Drug Dual-Carriers Delivery System with Mitochondria-Targeted and pH/Heat Responsive Capacity for Synergistic Photothermal-Chemotherapy of Ovarian Cancer
- (2020) Xiaoxia Guo et al. International Journal of Nanomedicine
- Research and development of drug delivery systems based on drug transporter and nano-formulation
- (2020) Yi Peng et al. Asian Journal of Pharmaceutical Sciences
- Magnetic casein-CaFe2O4 nanohybrid carrier conjugated with progesterone for enhanced cytotoxicity of citrus peel derived hesperidin drug towards breast and ovarian cancer
- (2020) Bindhya K. Purushothaman et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer
- (2020) Masaki Kobayashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer
- (2020) Jiyang Xue et al. International Journal of Nanomedicine
- Efficiency of nanoparticles for treatment of ocular infections: Systematic literature review
- (2020) Shahrzad Ghafoorianfar et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- A Co-Delivery System of Curcumin and p53 for Enhancing the Sensitivity of Drug-Resistant Ovarian Cancer Cells to Cisplatin
- (2020) Xinli Guo et al. MOLECULES
- Doxorubicin hydrochloride loaded nanotextured films as a novel drug delivery platform for ovarian cancer treatment
- (2020) Gökçen Yaşayan et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer
- (2020) L.R. Duska et al. GYNECOLOGIC ONCOLOGY
- Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment
- (2020) Yuzhu Hu et al. International Journal of Nanomedicine
- Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy
- (2020) Changbing Wang et al. International Journal of Nanomedicine
- A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum‐Sensitive Ovarian Cancer
- (2020) Sandro Pignata et al. ONCOLOGIST
- Tunneling Nanotubular Expressways for Ultrafast and Accurate M1 Macrophage Delivery of Anticancer Drugs to Metastatic Ovarian Carcinoma
- (2019) Ling Guo et al. ACS Nano
- Molecular modeling and experimental study of a new peptide-based microextraction fiber for preconcentrating morphine in urine samples
- (2019) Bamdad Riahi-Zanjani et al. JOURNAL OF MOLECULAR MODELING
- Silica Coated Paclitaxel Nanocrystals Enable Neural Stem Cell Loading For Treatment of Ovarian Cancer
- (2019) Pamela Tiet et al. BIOCONJUGATE CHEMISTRY
- Antineoplastic nano-lipobubbles for passively targeted ovarian cancer therapy
- (2019) Derusha Frank et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Natamycin solid lipid nanoparticles – sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization
- (2019) Ahmed Khames et al. International Journal of Nanomedicine
- Potential application of amino acids in analytical toxicology
- (2019) Bamdad Riahi-Zanjani et al. TALANTA
- Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer
- (2019) Shu Li et al. Drug Design Development and Therapy
- Functionalized graphene oxide as a nanocarrier for dual drug delivery applications: The synergistic effect of quercetin and gefitinib against ovarian cancer cells
- (2019) Himani Tiwari et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells
- (2019) Somayeh Vandghanooni et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A randomized phase III trial in patients with recurrent platinum sensitive ovarian cancer comparing efficacy and safety of paclitaxel micellar and Cremophor EL-paclitaxel
- (2019) I. Vergote et al. GYNECOLOGIC ONCOLOGY
- Paclitaxel-Loaded Self-Assembled Lipid Nanoparticles as Targeted Drug Delivery Systems for the Treatment of Aggressive Ovarian Cancer
- (2018) Jiali Zhai et al. ACS Applied Materials & Interfaces
- In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers
- (2018) Niravkumar R. Patel et al. CANCER BIOLOGY & THERAPY
- Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer
- (2018) Pranali Deshpande et al. DRUG DELIVERY
- Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer
- (2018) Ga Hee Kim et al. DRUG DELIVERY
- Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex® nanoparticles for docetaxel delivery in ovarian cancer
- (2018) Erfaneh Ghassami et al. International Journal of Nanomedicine
- Effect of amino acid substitution on biological activity of cyanophlyctin-β and brevinin-2R
- (2018) Adel Ghorani-Azam et al. JOURNAL OF MOLECULAR STRUCTURE
- In vitro and in vivo evaluation of folate receptor-targeted a novel magnetic drug delivery system for ovarian cancer therapy
- (2018) Güliz Ak et al. Artificial Cells Nanomedicine and Biotechnology
- PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy
- (2018) Jinju Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Encapsulation of verapamil and doxorubicin by MPEG-PLA to reverse drug resistance in ovarian cancer
- (2018) Weiping Zheng et al. BIOMEDICINE & PHARMACOTHERAPY
- CD44-targeted PLGA nanoparticles incorporating paclitaxel and FAK siRNA overcome chemoresistance in epithelial ovarian cancer
- (2018) Yeongseon Byeon et al. CANCER RESEARCH
- Recent advances in "smart" delivery systems for extended drug release in cancer therapy
- (2018) Regina-Veronicka Kalaydina et al. International Journal of Nanomedicine
- Macropinocytosis activated by oncogenic Dbl enables specific targeted delivery of Tat/pDNA nano-complexes into ovarian cancer cells
- (2018) Xiuran Niu et al. International Journal of Nanomedicine
- Dendrimers: A versatile nanocarrier for drug delivery and targeting
- (2018) Atul P. Sherje et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery
- (2018) Yingli Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Development, characterization and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles
- (2018) Juliana Palma Abriata et al. Materials Science & Engineering C-Materials for Biological Applications
- Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
- (2017) Fakhar ud Din et al. International Journal of Nanomedicine
- RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery
- (2017) Fengmei Pi et al. Nanomedicine-Nanotechnology Biology and Medicine
- Active targeting co-delivery system based on hollow mesoporous silica nanoparticles for antitumor therapy in ovarian cancer stem-like cells
- (2017) Xin Guo et al. ONCOLOGY REPORTS
- Exosomal delivery of berry anthocyanidins for the management of ovarian cancer
- (2017) Farrukh Aqil et al. Food & Function
- Epidemiology of ovarian cancer: a review
- (2017) Reid Brett M. et al. Cancer Biology & Medicine
- Integrated self-assembling drug delivery system possessing dual responsive and active targeting for orthotopic ovarian cancer theranostics
- (2016) Chun-Jui Lin et al. BIOMATERIALS
- A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
- (2016) Alice Soragni et al. CANCER CELL
- Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth
- (2016) Yu-Hung Huang et al. CANCER RESEARCH
- Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals
- (2016) Bo Sun et al. JOURNAL OF CONTROLLED RELEASE
- Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies
- (2016) Katsutoshi Oda et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Nanoscale Coordination Polymers Codeliver Chemotherapeutics and siRNAs to Eradicate Tumors of Cisplatin-Resistant Ovarian Cancer
- (2016) Chunbai He et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells
- (2016) Emiliano Cocco et al. MOLECULAR CANCER THERAPEUTICS
- Cyclic RGDfK Peptide Functionalized Polymeric Nanocarriers for Targeting Gemcitabine to Ovarian Cancer Cells
- (2016) Hitesh Kulhari et al. MOLECULAR PHARMACEUTICS
- Paclitaxel-Loaded Mixed Micelles Enhance Ovarian Cancer Therapy through Extracellular pH-Triggered PEG Detachment and Endosomal Escape
- (2016) Haijun Zhao et al. MOLECULAR PHARMACEUTICS
- Targeted chimera delivery to ovarian cancer cells by heterogeneous gold magnetic nanoparticle
- (2016) Yao Chen et al. NANOTECHNOLOGY
- Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model
- (2016) Bhushan S. Pattni et al. PHARMACEUTICAL RESEARCH
- Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study†
- (2015) B. J. Monk et al. ANNALS OF ONCOLOGY
- Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance
- (2015) Liping Wang et al. DRUG DELIVERY
- Molecular Communication Modeling of Antibody-Mediated Drug Delivery Systems
- (2015) Youssef Chahibi et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Antibody fragment-armed mesoporous silica nanoparticles for the targeted delivery of bevacizumab in ovarian cancer cells
- (2015) Ying Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeted delivery of platinum-taxane combination therapy in ovarian cancer
- (2015) Swapnil S. Desale et al. JOURNAL OF CONTROLLED RELEASE
- Lipid-dendrimer hybrid nanosystem as a novel delivery system for paclitaxel to treat ovarian cancer
- (2015) Yuanjie Liu et al. JOURNAL OF CONTROLLED RELEASE
- Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery
- (2015) Chiara Romani et al. Oncotarget
- Evaluation of antibacterial properties of Barium Zirconate Titanate (BZT) nanoparticle
- (2015) Simin Mohseni et al. BRAZILIAN JOURNAL OF MICROBIOLOGY
- Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug
- (2015) Jlenia Brunetti et al. Scientific Reports
- Biocompatible APTES–PEG Modified Magnetite Nanoparticles: Effective Carriers of Antineoplastic Agents to Ovarian Cancer
- (2014) Amaneh Javid et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Dual-Layer Surface Coating of PLGA-Based Nanoparticles Provides Slow-Release Drug Delivery To Achieve Metronomic Therapy in a Paclitaxel-Resistant Murine Ovarian Cancer Model
- (2014) Zohreh Amoozgar et al. BIOMACROMOLECULES
- PEGylated dendritic diaminocyclohexyl-platinum (II) conjugates as pH-responsive drug delivery vehicles with enhanced tumor accumulation and antitumor efficacy
- (2014) Dayi Pan et al. BIOMATERIALS
- Cisplatin–alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells
- (2014) Yunfei Wang et al. BIOMATERIALS
- Follicle-stimulating hormone polypeptide modified nanoparticle drug delivery system in the treatment of lymphatic metastasis during ovarian carcinoma therapy
- (2014) Lingling Fan et al. GYNECOLOGIC ONCOLOGY
- Ultrasound-assisted siRNA delivery via arginine-grafted bioreducible polymer and microbubbles targeting VEGF for ovarian cancer treatment
- (2014) Stelios Florinas et al. JOURNAL OF CONTROLLED RELEASE
- Combination of Dendrimer-Nanovector-Mediated Small Interfering RNA Delivery to Target Akt with the Clinical Anticancer Drug Paclitaxel for Effective and Potent Anticancer Activity in Treating Ovarian Cancer
- (2014) Shashwati Kala et al. JOURNAL OF MEDICINAL CHEMISTRY
- Systematic Reviews of Animal Studies; Missing Link in Translational Research?
- (2014) Judith van Luijk et al. PLoS One
- Purification and Modeling Amphipathic Alpha Helical Antimicrobial Peptides from Skin Secretions ofEuphlyctis cyanophlyctis
- (2013) Ahmad Asoodeh et al. Chemical Biology & Drug Design
- Polymeric Mixed Micelles for Delivery of Curcumin to Multidrug Resistant Ovarian Cancer
- (2013) Vipin Saxena et al. Journal of Biomedical Nanotechnology
- LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian Cancer
- (2013) Natalia V. Nukolova et al. MOLECULAR PHARMACEUTICS
- Magneto-electric Nanoparticles to Enable Field-controlled High-Specificity Drug Delivery to Eradicate Ovarian Cancer Cells
- (2013) Rakesh Guduru et al. Scientific Reports
- Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis
- (2012) Bradley J. Monk et al. EUROPEAN JOURNAL OF CANCER
- Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin
- (2012) Xin-Tao Shuai International Journal of Nanomedicine
- Phosphatidylinositol 3-kinase Inhibitor (PIK75) Containing Surface Functionalized Nanoemulsion for Enhanced Drug Delivery, Cytotoxicity and Pro-apoptotic Activity in Ovarian Cancer Cells
- (2012) Meghna Talekar et al. PHARMACEUTICAL RESEARCH
- Aptamers and Their Biological Applications
- (2012) Kyung-Mi Song et al. SENSORS
- Nanocarriers Enhance Doxorubicin Uptake in Drug-Resistant Ovarian Cancer Cells
- (2011) H. C. Arora et al. CANCER RESEARCH
- Identification and Characterization of Novel Antibacterial Peptides from Skin Secretions of Euphlyctis cyanophlyctis
- (2011) Ahmad Asoodeh et al. International Journal of Peptide Research and Therapeutics
- Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial
- (2010) A. Poveda et al. ANNALS OF ONCOLOGY
- Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval
- (2010) S. B. Kaye et al. ANNALS OF ONCOLOGY
- Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancer
- (2010) S Fujiwara et al. CANCER GENE THERAPY
- Nonviral gene delivery to human ovarian cancer cells using arginine-grafted PAMAM dendrimer
- (2010) Soo Hyun Jang et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- An Optimized RGD-Decorated Micellar Drug Delivery System for Albendazole for the Treatment of Ovarian Cancer: From RAFT Polymer Synthesis to Cellular Uptake
- (2010) Yoseop Kim et al. MACROMOLECULAR BIOSCIENCE
- Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells
- (2010) M. S. Goldberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug delivery systems: Advanced technologies potentially applicable in personalized treatments
- (2010) Jorge F. Coelho et al. EPMA Journal
- A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer
- (2009) Kai Xiao et al. BIOMATERIALS
- Phase II Evaluation of Nanoparticle Albumin–Bound Paclitaxel in Platinum-Sensitive Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
- (2009) Michael G. Teneriello et al. JOURNAL OF CLINICAL ONCOLOGY
- Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
- (2009) Henry T. Lynch et al. Molecular Oncology
- RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer
- (2008) Hui Zhao et al. JOURNAL OF DRUG TARGETING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More